CELLULAR NANOPARTICLE (CNP)
Live / Applied — Fourth extension granted (statement of use) (as of 17 Jul 2025)
What this means for you
Not registered yet, but its 26 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97430828
- Mark type
- Stylized text
- Filed
- 26 May 2022
- Published for opposition
- 13 Jun 2023
- Attorney of record
- Letao Qin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, cell membrane-coated nanoparticles used as drug delivery vehicles for targeted delivery of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, cell membrane-coated nanoparticles used as therapeutic pharmaceuticals for the treatment of infectious disease, cancer, inflammatory disease, cardiovascular disease, and autoimmune disease
Owner
- Arytha Biosciences, LLC, San Diego, CA, US
- Arytha Biosciences, LLC, San Diego, CA, US
Prosecution history
- 30 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 18 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jul 2025 — SOU EXTENSION 4 GRANTED
- 17 Jul 2025 — SOU EXTENSION 4 FILED
- 17 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Jan 2025 — SOU EXTENSION 3 GRANTED
- 27 Jan 2025 — SOU EXTENSION 3 FILED
- 27 Jan 2025 — SOU TEAS EXTENSION RECEIVED
- 17 May 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 May 2024 — SOU EXTENSION 2 GRANTED
- 16 May 2024 — SOU EXTENSION 2 FILED
- 16 May 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Jan 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jan 2024 — SOU EXTENSION 1 GRANTED